619
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Association between pulse width and health-related quality of life after electroconvulsive therapy in patients with unipolar or bipolar depression: an observational register-based study

, , ORCID Icon, , &
Pages 137-145 | Received 14 Jul 2023, Accepted 12 Nov 2023, Published online: 11 Dec 2023

References

  • GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1789–1858. doi: 10.1016/S0140-6736(18)32279-7.
  • IsHak WW, Greenberg JM, Balayan K, et al. Quality of life: the ultimate outcome measure of interventions in major depressive disorder. Harv Rev Psychiatry. 2011;19(5):229–239. doi: 10.3109/10673229.2011.614099.
  • Leiknes KA, Jarosh-von Schweder L, Høie B. Contemporary use and practice of electroconvulsive therapy worldwide. Brain Behav. 2012;2(3):283–344. doi: 10.1002/brb3.37.
  • Semkovska M, McLoughlin DM. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol Psychiatry. 2010;68(6):568–577. doi: 10.1016/j.biopsych.2010.06.009.
  • UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet. 2003;361(9360):799–808. doi: 10.1016/S0140-6736(03)12705-5.
  • van Diermen L, van den Ameele S, Kamperman AM, et al. Prediction of electroconvulsive therapy response and remission in major depression: meta-analysis. Br J Psychiatry. 2018;212(2):71–80. doi: 10.1192/bjp.2017.28.
  • Spaans HP, Kho KH, Verwijk E, et al. Efficacy of ultrabrief pulse electroconvulsive therapy for depression: a systematic review. J Affect Disord. 2013;150(3):720–726. doi: 10.1016/j.jad.2013.05.072.
  • Peterchev AV, Rosa MA, Deng ZD, et al. Electroconvulsive therapy stimulus parameters: rethinking dosage. J Ect. 2010;26(3):159–174. doi: 10.1097/YCT.0b013e3181e48165.
  • Sackeim HA, Prudic J, Nobler MS, et al. Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimul. 2008;1(2):71–83. doi: 10.1016/j.brs.2008.03.001.
  • Sienaert P, Spaans HP, Kellner CH. Pulse width in electroconvulsive therapy: how brief Is brief? J Ect. 2018;34(2):73–74. doi: 10.1097/YCT.0000000000000490.
  • Loo CK, Katalinic N, Martin D, et al. A review of ultrabrief pulse width electroconvulsive therapy. Ther Adv Chronic Dis. 2012;3(2):69–85. doi: 10.1177/2040622311432493.
  • Tor PC, Bautovich A, Wang MJ, et al. A systematic review and Meta-Analysis of brief Versus ultrabrief right unilateral electroconvulsive therapy for depression. J Clin Psychiatry. 2015;76(9):e1092–e1098. doi: 10.4088/JCP.14r09145.
  • Galvez V, Li A, Oxley C, et al. Health related quality of life after ECT for depression: a study exploring the role of different electrode-placements and pulse-widths. J Affect Disord. 2016;206:268–272. doi: 10.1016/j.jad.2016.08.002.
  • Giacobbe P, Rakita U, Penner-Goeke K, et al. Improvements in health-related quality of life with electroconvulsive therapy: a meta-analysis. J Ect. 2018;34(2):87–94. doi: 10.1097/YCT.0000000000000486.
  • Guney P, Ekman CJ, Hammar A, et al. Electroconvulsive therapy in depression: improvement in quality of life depending on age and sex. J Ect. 2020;36(4):242–246. doi: 10.1097/YCT.0000000000000671.
  • Huang CJ, Huang YH, Lin CH. Factors related to the changes in quality of life for patients with depression after an acute course of electroconvulsive therapy. J Ect. 2017;33(2):126–133. doi: 10.1097/YCT.0000000000000358.
  • Ernstsson O, Zethraeus N, Heintz E, et al. Association between pulse width and health-related quality of life following electroconvulsive therapy (Study Protocol): Open Science Framework; 2020. https://osf.io/vxyag/.
  • von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344–349. doi: 10.1016/j.jclinepi.2007.11.008.
  • Nordanskog P, Hulten M, Landen M, et al. Electroconvulsive therapy in Sweden 2013: data From the national quality register for ECT. J Ect. 2015;31(4):263–267. doi: 10.1097/YCT.0000000000000243.
  • Ahmad I, Sandberg M, Brus O, et al. Validity of diagnoses, treatment dates, and rating scales in the swedish national quality register for electroconvulsive therapy. Nord J Psychiatry. 2021;76(2):96–103.
  • Elvin T, Nordenskjöld A. Kvalitetsregister ECT Årsrapport 2019. 2019. https://registercentrum.blob.core.windows.net/ect/r/-rsrapport2019_ECT-utan_PARdocx-rklzVIXM2U.pdf.
  • Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35(11):1095–1108. doi: 10.1097/00005650-199711000-00002.
  • Devlin N, Parkin D, Janssen B. Methods for analysing and reporting EQ-5D data. Cham: Springer; 2020 [cited 2021 Apr 29]. 10.1007/978-3-030-47622-9.
  • Luo N, Johnson J, Coons SJ. Using instrument-defined health state transitions to estimate minimally important differences for four preference-based health-related quality of life instruments. Med Care. 2010;48(4):365–371. doi: 10.1097/mlr.0b013e3181c162a2.
  • Pickard AS, Neary MP, Cella D. Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes. 2007;5(1):70. doi: 10.1186/1477-7525-5-70.
  • Matthay EC, Hagan E, Gottlieb LM, et al. Powering population health research: considerations for plausible and actionable effect sizes. SSM Popul Health. 2021;14:100789. doi: 10.1016/j.ssmph.2021.100789.
  • Vickers AJ, Altman DG. Statistics notes: analysing controlled trials with baseline and follow up measurements. BMJ. 2001;323(7321):1123–1124. doi: 10.1136/bmj.323.7321.1123.
  • Pullenayegum EM, Tarride JE, Xie F, et al. Analysis of health utility data when some subjects attain the upper bound of I: are tobit and CLAD models appropriate? Value Health. 2010;13(4):487–494. doi: 10.1111/j.1524-4733.2010.00695.x.